Sign inJoin waitlistJoin the waitlist

Kasia Lipska

Vice Chief, Collaborative Excellence · Yale-New Haven Hospital

Credentials: · · · · · ·

History

Collaborative Excellence · Yale-New Haven Hospital
Present
Yale-New Haven Hospital
Present
Yale-New Haven Hospital · Yale School of Medicine
Present

Endocrinology, Diabetes, and Metabolism
2012–2014
Public Health Foundation of India
2010–2012
Public Health Foundation of India
2011–2012
Yale University School of Medicine
2011
Geriatric Medicine
Yale-New Haven Hospital
2008–2009
Brigham and Women's Hospital
2003–2006
Harvard Medical School
1999–2003
Yale University, Molecular Biochemistry and Biophysics
1993–1997
Internal Medicine
Yale University
1994–1997
Resident
Yale University

Research

Metformin in patients with type 2 diabetes and kidney disease: a systematic review
Systematic review or meta-analysis · JAMA · 2014 · 462 citations
Metformin in 2019
Review · JAMA · 2019 · 352 citations
Potential overtreatment of diabetes mellitus in older adults with tight glycemic control
JAMA Internal Medicine · 2015 · First of 6 authors · 324 citations

Rozalina McCoy
22 papers · 7 as a fellow
Elbert Huang
19 papers
HK
Harlan Krumholz
19 papers
JR
Joseph Ross
19 papers
MK
Mikhail Kosiborod
17 papers
Silvio Inzucchi
17 papers
Victor Montori
16 papers
John Spertus
12 papers
Darren McGuire
10 papers
Neda Laiteerapong
10 papers
Suzanne Arnold
9 papers
AG
Abhinav Goyal
8 papers

Grants

"Insulin Affordability: Unpacking the Impact of the Inflation Reduction Act on Diabetes Outcomes in Medicare."
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $1.5M · Yale University
2025–2028
Addressing Social Determinants of Health in Young Adults with Type 1 Diabetes Through Comprehensive Assessment, Responsiveness, and Engagement (T1CARE)
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $981K · Yale University
2025–2027
Evidence-Based Targets for Continuous Glucose Monitoring Metrics in Adults with Type 1 Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases · R56
PI · $370K · Kaiser Foundation Research Institute
2026–2027
QBSafe: A Randomized Trial of a Novel Intervention to Improve Care for People Living with Type 2 Diabetes.
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $839.8K · Yale University
2022–2026

Clinical trials

T1CARE: A Trial of a Novel Intervention to Address Social Determinants of Health in Young Adults With Type 1 Diabetes
Principal investigator · Recruiting
Yale University
2025–2027
Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access
Principal investigator · Recruiting
Yale University
2024–2026
QBSafe: a Randomized Trial of a Novel Intervention to Improve Care for People Living With Type 2 Diabetes.
Principal investigator · Completed
Yale University
2022–2025